Incidence of cytomegalovirus infection after allogeneic stem cell transplantation conditioned with myeloablative and non-myeloablative regimens

被引：0
|
作者：
Irrera, I
Morabito, F
Cuzzola, M
Cuzzocrea, A
Iacopino, O
Penna, G
Console, G
Messina, G
Martino, M
Iacopino, P
机构：
来源：
BONE MARROW TRANSPLANTATION | 2003年 / 31卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S97 / S97
页数：1
相关论文
共 50 条
  • [1] Risk for cytomegalovirus infection following non-myeloablative allogeneic stem cell transplantation
    Nachbaur, D
    Gunsilius, E
    Haun, M
    Larcher, C
    Gastl, G
    BONE MARROW TRANSPLANTATION, 2003, 31 : S96 - S97
  • [2] Cytomegalovirus (CMV) infection in allogeneic non-myeloablative stem cell transplantation recipients
    Chandrasekar, P
    King, R
    Dansey, R
    Akhtar, A
    Mellon-Reppen, S
    Alangaden, G
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2004, 10 (02) : 43 - 43
  • [3] Low incidence of infectious complications after non-myeloablative compared with myeloablative allogeneic stem cell transplantation
    Meijer, E
    Dekker, A
    Lokhorst, H
    Petersen, E
    Nieuwenhuis, K
    BONE MARROW TRANSPLANTATION, 2005, 35 : S198 - S198
  • [4] Allogeneic stem cell transplantation using non-myeloablative transplant regimens
    Körbling, M
    Khouri, I
    HIGH-DOSE THERAPY AND TRANSPLANTATION OF HAEMATOPOIETIC STEM CELLS, 2000, : 175 - 184
  • [5] Pseudothrombocytopenia after allogeneic non-myeloablative stem cell transplantation
    Gillis, S
    Eisenberg, ME
    Shapira, MY
    Or, R
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2003, 5 (09): : 671 - 673
  • [6] Impact of unrelated donor status on the incidence and outcome of cytomegalovirus infections after non-myeloablative allogeneic stem cell transplantation
    Junghanss, C
    Storb, R
    Maris, MB
    Carter, RA
    Sandmaier, BM
    Maloney, DG
    McSweeney, PA
    Corey, L
    Boeckh, M
    BRITISH JOURNAL OF HAEMATOLOGY, 2003, 123 (04) : 662 - 670
  • [7] Allogeneic transplantation using non-myeloablative transplant regimens
    Battiwalla, M
    Barrett, J
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2001, 14 (04) : 701 - 722
  • [8] Clinical cytomegalovirus disease in allogeneic non-myeloablative stem cell transplantation recipients.
    Ruiz-Argüelles, GJ
    Gómez-Almaguer, D
    López-Martinez, B
    Ponce-de-León, S
    Cantú-Rodríguez, OG
    Jaime-Pérez, JC
    BLOOD, 2001, 98 (11) : 362B - 362B
  • [9] Non-myeloablative stem cell transplantation - High stem cell dose will not compensate for T cell depletion in allogeneic non-myeloablative stem cell transplantation
    Passweg, JR
    Meyer-Monard, S
    Gregor, M
    Favre, G
    Heim, D
    Ebnoether, M
    Tichelli, A
    Gratwohl, A
    BONE MARROW TRANSPLANTATION, 2002, 30 (05) : 267 - 271
  • [10] Engraftment and transfusion requirements after autologous haernatopoietic stem cell transplantation with myeloablative and non-myeloablative conditioning regimens
    Golovchenko, R
    Moiseev, S
    BONE MARROW TRANSPLANTATION, 2005, 35 : S347 - S347
12345